发明名称 Modulation of phosphatidylinositol-5-phosphate-4-kinase activity
摘要 The invention features methods for identifying compounds that modulate the activity of phosphatidylinositol 5-phosphate 4-kinase (PI5P4K). Inhibitors of PI5P4K can be used in, for example, the treatment or prevention of cell proliferation disorders (e.g., the prevention of tumor cell growth in p53 mutated cancers).
申请公布号 US9493813(B2) 申请公布日期 2016.11.15
申请号 US201213985462 申请日期 2012.01.13
申请人 Beth Israel Deaconess Medical Center, Inc. 发明人 Emerling Brooke;Sasaki Atsuo;Cantley Lewis C.;Hurov Jonathan
分类号 C12Q1/68;C12Q1/48;A61K31/7105;C12N15/11 主分类号 C12Q1/68
代理机构 Clark & Elbing LLP 代理人 Bicker-Brandy Kristina;Clark & Elbing LLP
主权项 1. A method for identifying a compound that inhibits phosphatidylinositol-5-phosphate-4-kinase (PI5P4K), said method comprising: (a) providing a cell expressing a phosphatidylinositol-5-phosphate-4-kinase (PI5P4K) and comprising a p53-inactive mutation or a p53-deletion and a substrate; (b) contacting said cell with a candidate compound; (c) detecting the activity of said PI5P4K; and (d) determining if said candidate compound inhibits said PI5P4K; wherein said candidate compound is a preferred candidate for treating a p53-mutated cancer if said candidate compound inhibits said PI5P4K, and wherein said cell is not a leukemia cell.
地址 Boston MA US